EGFR and lung carcinoma: In this study, we investigated the usefulness of ddPCR for quantitative detection of EGFR mutations in plasma samples and for guiding decisions regarding osimertinib therapy in lung cancer patients in a community setting who had developed resistance to first- or second-generation EGFR-TKI.